Dr Reddy’s Labs share price gains over launch of COVID-19 treatment drug – Moneycontrol.com

In the initial weeks, the Company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India, the company said in an exchange filing. Read More